Reference | Measure | Pre-treatment M (SD) | Post-treatment M (SD) | Within group Significance Pre-post | Within group Size effect (d) Pre-post | Follow-up M (SD) |
---|---|---|---|---|---|---|
Comer et al. (USA) [28] | Efficacy | |||||
CY-BOCS | 24.2 (5.2) c | 17.4 (5.9) c | Not Reported | 2.54 | Not Applicable | |
ADIS-IV-C/P (OCD CSR) | 6.2 (1.1) c | 4.0 (1.4) c | Not Reported | 5.88 | Not Applicable | |
CGAS | 51.8 d | 58.6 d | Not Reported | 2.87 | Not Applicable | |
CGI-S | 5.2 d | 3.6 d | Not Reported | Not Reported | Not Applicable | |
CGI-I | Not Applicable | 2.2 (0.8) c | Not Reported | Not Reported | Not Applicable | |
Acceptability | ||||||
CSQ-8 (First Item) | Not Applicable | All mothers rated quality as “Excellent” | Not Applicable | Not Applicable | Not Applicable | |
Feasibility | ||||||
Treatment dropout | Not Applicable | Dropout = 0 | Not Applicable | Not Applicable | Not Applicable | |
Farrell et al. (Australia) [31] | Efficacy | |||||
CYBOCS | 29.1 (4.2) | 14.8 (7.7) | p< 0.001 | 2.09 | 11.8 (8.9) b | |
CY-BOCS-SR (Parent) | 24.1(3.3) | 12.9 (7.3) | p< 0.001 | 1.94 | 11.5 (9.5) b | |
ADIS-IV-C/P (OCD CSR) | 6.6 (0.5) | 3.5 (2.0) | p< 0.001 | 2.28 | 3.3 (1.9) b | |
NIMH GOCS | 10.7 (1.8) | 6.3 (3.1) | p< 0.005 | 1.36 | 5.8 (3.6) b | |
CGI-S | 5.6 (0.5) | 3.1 (1.5) | p< 0.001 | 2.25 | 2.7 (1.6) b | |
CDI-S | 13.6 (10.9) | 10.3 (7.9) | p< 0.05 | 0.34 | Not Reported | |
MASC | 83.6 (35.0) | 60.1 (26.1) | p= n.s. | 0.76 | Not Reported | |
PEDSQL | 35.3 (12.1) | 18.5 (14.9) | p< 0.05 | 1.23 | Not Reported | |
Feasibility | ||||||
Treatment dropout | Not Applicable | Dropout = 0 | Not Applicable | Not Applicable | Not Applicable | |
Lenhard et al. (Sweden) [32] | Efficacy | |||||
CY-BOCS | 21.3 (3.5) | 12.1 (4.5) | p< 0.001 | 2.29 | 8.8 (5.1) a 9.1 (6.4) b | |
ChOCI –symptom Parent | 12.4 (6.8) | 6.5 (5.1) | p< 0.001 | 0.94 | 5.3 (5.6) a 4.5 (4.3) b | |
ChOCI –impairment Parent | 24.9 (7.0) | 17.8 (10.0) | p< 0.001 | 0.79 | 12.4 (8.1) a 11.5 (6.4) b | |
ChOCI –symptom child | 13.6 (8.7) | 6.4 (6.6) | p< 0.001 | 0.92 | 5.3 (6.7) a 5.0 (6.6) b | |
ChOCI – impairment child | 22.6 (8.1) | 11.6 (6.3) | p< 0.001 | 1.51 | 9.9 (8.9) a 10.4 (9.1) b | |
COIS-R Parent | 25.3 (16.1) | 16.8 (17.2) | p< 0.05 | 0.45 | 13.0 (15.7) a 13.9 (15.0) b | |
COIS-R Child | 17.3 (15.5) | 6.6 (7.9) | p< 0.001 | 0.88 | 5.2 (8.4) a 6.0 (9.0) b | |
CGI-I | Not Applicable | 52% “Much Improved” or “Very Much Improved” | Not Applicable | Not Applicable | 71 % “Much Improved” or “Very Much Improved” a b | |
CGAS | 56.1 (6.3) | 71.5 (9.3) | p< 0.001 | -1.94 | 74.0 (9.0) a 73.5 (9.7) b | |
CDI-S | 9.6 (1.4) | 9.9 (1.2) | p= n.s. | -0.19 | 2.5 (2.7) a 2.2 (2.1) b | |
FAS | 14.6 (8.4) | 9.6 (7.1) | p<0.05 | 0.60 | 6.9 (8.1) a 6.5 (6.9) b | |
SDQ Parent | 12.0 (6.7) | 10.3 (6.3) | p= n.s. | 0.29 | 10.3 (6.6) a 9.7 (6.4) b | |
SDQ child | 13.5 (5.5) | 10.6 (4.0) | p= n.s. | 0.61 | 10.7 (4.2) a 10.5 (4.8) b | |
SCAS without OCD Parent | 25.2 (15.7) | 16.0 (13.5) | p<0.001 | 0.63 | 16.4 (12.2) a 15.7 (14.1) b | |
SCAS OCD Child | 9.1 (5.0) | 4.1 (3.4) | p<0.001 | 1.17 | 2.9 (3.8) a 3.3 (4.0) b | |
SCAS without OCD Child | 30.4 (16.9) | 20.2 (13.5) | p<0.001 | 0.67 | 18.9 (14.0) a 18.3 (14.2) b | |
Acceptability | ||||||
Not Applicable | Not Applicable | Not Applicable | Not Applicable | Not Applicable | Not Applicable | |
Feasibility | ||||||
Treatment dropout | Not Applicable | 8.3/12 Chapters completed by patients (3.0) | Not Applicable | Not Applicable | Not Applicable | |
4.7/5 Chapters completed by parents (0.8) |